(Q37413086)

20 August 2017

1 reference

title

Carnitine in the treatment of valproic acid-induced toxicity (English)

1 reference

20 August 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

39867

author name string

Philippe E R Lheureux

series ordinal

1

1 reference

20 August 2017

Philippe Hantson

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

47

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

101-111

1 reference

Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Multicenter case series of valproic acid ingestion: serum concentrations and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid toxicity: overview and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Carnitine as an essential nutrient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Carnitine metabolism and deficit--when supplementation is necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Carnitine, valproate, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid associated abnormalities of carnitine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

The role of carnitine supplementation during valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate therapy does not deplete carnitine levels in otherwise healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Carnitine level in Chinese epileptic patients taking sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Hepatotoxicity associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Life threatening intoxication with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Acute hepatic failure associated with valproic acid in children. Report of 3 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Unusual electronmicroscopic changes in valproate-associated liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Reye-like syndrome associated with valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Decreased serum carnitine in valproate induced Reye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Serum carnitine during valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Effect of L-carnitine treatment for valproate-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Effect of L-carnitine treatment for valproate-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid-induced hyperammonemia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Severe acute hyperammonemia after brief exposure to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Clinical pharmacokinetics of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Effect of L-carnitine supplementation on acute valproate intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate-associated hyperammonemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate-induced hyperammonemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Hyperammonemia and valproic acid-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Hepatic and renal contributions to valproic acid-induced hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Nutritional influence on serum ammonia in young patients receiving sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Sodium valproate-induced hyperammonemia in the rat: role of the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

The renal origin of sodium valproate-induced hyperammonemia in fasting humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Metabolic viability and pharmaco-toxicological reactivity of cryopreserved human precision-cut renal cortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Cerebral edema following acute sodium valproate overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproate induced encephalopathy treated with carnitine in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Valproic acid overdose and haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Haemodialysis, L-carnitine therapy and valproic acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Two cases of valproic acid poisoning treated with L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

A case of hemoperfusion and L-carnitine management in valproic acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

L-carnitine was safely administered in the setting of valproate toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

Carnitine as an antidote for acute valproate toxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15563650902752376

10.1080/15563650902752376

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference